Burg, S. H. v. d., Hall, T. v., Vroman, H., Nimwegen, M. v., Groeneveldt, C., Kinderman, P., . . . Dammeijer, F. Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model. BMJ Publishing Group.
Chicago Style (17th ed.) CitationBurg, Sjoerd H van der, et al. Dendritic Cell Vaccination and CD40-agonist Combination Therapy Licenses T Cell-dependent Antitumor Immunity in a Pancreatic Carcinoma Murine Model. BMJ Publishing Group.
MLA (9th ed.) CitationBurg, Sjoerd H van der, et al. Dendritic Cell Vaccination and CD40-agonist Combination Therapy Licenses T Cell-dependent Antitumor Immunity in a Pancreatic Carcinoma Murine Model. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.